Predictors of mortality among HIV infected patients taking antiretroviral treatment in Ethiopia: a retrospective cohort study

January 2012
AIDS Research & Therapy;2012, Vol. 9, p15
Academic Journal
The article offers information regarding a study which aimed to examine mortality and its predictors among a cohort of HIV infected patients on anti-retroviral treatment retrospectively followed for five years in Ethiopia. As reported, a total of 1540 study participants were included. As stated, in multivariate analysis, the independent predictors for mortality were loss of more than 10 percent weight loss, bedridden functional status at baseline.


Related Articles

  • Incidence of Tuberculosis during Highly Active Antiretroviral Therapy in High-Income and Low-Income Countries. Lawn, Stephen D.; Wood, Robin // Clinical Infectious Diseases;12/15/2005, Vol. 41 Issue 12, p1783 

    The article presents the author's comments on the incidence of Tuberculosis during highly active antiretroviral therapy in high-income and low-income countries. Highly active antiretroviral therapy (HAART) has revolutionized the care of HIV-infected individuals, causing major reductions in...

  • Editorial Commentary: Addressing Disparities in HIV Mortality: Antiretroviral Therapy Is Necessary but Not Sufficient. Smith, Kimberly Y. // Clinical Infectious Diseases;Jun2013, Vol. 56 Issue 12, p1810 

    An introduction is presented in which the editor discusses the study which examines the influence of geographic origin and race/ethnicity on HIV mortality in patients on antiretroviral therapy (ART) in Canada, Europe, and the U.S.

  • HIV-positive people on ART have the same mortality risk to HIV-negative people.  // HIV Australia;2013, Vol. 11 Issue 2, p5 

    The article presents information on a report according to which HIV-positive persons responding well to antiretroviral therapy have no higher mortality risk as compared to their HIV-negative peers.

  • Early Initiation of ART Produces Better Clinical Outcomes.  // Clinical Infectious Diseases;4/15/2009, Vol. 48 Issue 8, following p1167 

    The article presents the results of 2 clinical trials related to effectiveness of antiretroviral therapy on acquired immuno deficiency syndrome (AIDS) patients. The results of North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) state that the antiretroviral naive...

  • Relevance of Interleukin-6 and D-Dimer for Serious Non-AIDS Morbidity and Death among HIV-Positive Adults on Suppressive Antiretroviral Therapy. Grund, Birgit; Baker, Jason V; Deeks, Steven G.; Wolfson, Julian; Wentworth, Deborah; Cozzi-Lepri, Alessandro; Cohen, Calvin J.; Phillips, Andrew; Lundgren, Jens D.; Neaton, James D.; null, null // PLoS ONE;5/12/2016, Vol. 11 Issue 5, p1 

    Background: Despite effective antiretroviral treatment (ART), HIV-positive individuals are at increased risk of serious non-AIDS conditions (cardiovascular, liver and renal disease, and cancers), perhaps due in part to ongoing inflammation and/or coagulation. To estimate the potential risk...

  • Temporal Trends in Presentation and Survival for HIV-Associated Lymphoma in the Antiretroviral Therapy Era. Gopal, Satish; Patel, Monita R.; Yanik, Elizabeth L.; Cole, Stephen R.; Achenbach, Chad J.; Napravnik, Sonia; Burkholder, Greer A.; Reid, Erin G.; Rodriguez, Benigno; Deeks, Steven G.; Mayer, Kenneth H.; Moore, Richard D.; Kitahata, Mari M.; Eron, Joseph J.; Richards, Kristy L. // JNCI: Journal of the National Cancer Institute;8/21/2013, Vol. 105 Issue 16, p1221 

    Background Lymphoma is the leading cause of cancer-related death among HIV-infected patients in the antiretroviral therapy (ART) era. Methods We studied lymphoma patients in the Centers for AIDS Research Network of Integrated Clinical Systems from 1996 until 2010. We examined differences...

  • Factors Influencing the Acceptance of Changes in Antiretroviral Therapy among HIV-1–Infected Patients. Campo, Rafael E.; Narayanan, Siva; Clay, Patrick G.; Dehovitz, Jack; Johnson, Debra; Jordan, Wilbert; Squires, Kathleen E.; Sajjan, Shiva G.; Markson, Leona E. // AIDS Patient Care & STDs;May2007, Vol. 21 Issue 5, p329 

    Physicians routinely consider modifying antiretroviral therapy (ART) regimen for their patients with HIV. Little is known about the factors associated with patients′ willingness to accept providers′ recommended ART changes. This multicenter prospective observational study examined...

  • Mortality and Morbidity of HIV Infected Patients Receiving HAART: A Cohort Study. Panos, George; Samonis, George; Alexiou, Vangelis G.; Kavarnou, Garyfallia A.; Charatsis, Gerasimos; Falagas, Matthew E. // Current HIV Research;May2008, Vol. 6 Issue 3, p257 

    HAART has substantially decreased mortality and morbidity among HIV-infected patients. We retrospectively analyzed morbidity and mortality in a cohort of HIV-infected adult patients with prolonged and frequent follow up (1987-2006). The study was divided in pre-HAART and HAART period for...

  • Mortality among HIV-Infected Patients in Resource Limited Settings: A Case Controlled Analysis of Inpatient's at a Community Care Center. Rajagopalan, Nirmala; Suchitra, Joyce B.; Shet, Anita; Khan, Zafar K.; Martin-Garcia, Julio; Nonnemacher, Michael R.; Jacobson, Jeffrey M.; Wigdahl, Brian // American Journal of Infectious Diseases;2009, Vol. 5 Issue 3, p219 

    Problem statement: Despite massive national efforts to scale up Antiretroviral Therapy (ART) access in India since 2004, the AIDS death rate was 17.2 per 100,000 persons during 2003- 2005. In the era of HAART in resource poor settings, it is imperative to understand and address the causes of...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics